Loading organizations...
Paragon Ventures operates as a specialized merger and acquisition advisory firm, focusing on private mid-market companies within the healthcare sector. The firm offers comprehensive services across the transaction lifecycle, guiding clients from strategic planning and valuation through negotiation and deal closure. Their expertise ensures tailored solutions for complex business transitions.
The company was founded in 1994 by Marc S. Rose and Richard G. Davis Jr. Their insight recognized a market need to assist healthcare companies in navigating the complexities of selling their businesses. This foundational understanding allowed Paragon Ventures to build a robust advisory practice, with Marc S. Rose as its president.
Paragon Ventures serves private mid-market businesses across the healthcare continuum seeking to execute strategic transactions. The firm's vision is to be the premier partner for these entities, facilitating seamless and successful business transitions that align with their long-term objectives and unlock future opportunities.
Paragon Ventures has 1 tracked investment across 1 company. The latest tracked deal is $9.0M Seed in FLORA in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2022 | FLORA | $9.0M Seed | — | Tribe Capital, Nate Matherson, Rolf Schrömgens, Fatih Isbecer, Firat Isbecer, Gokul Rajaram, MR. ROB Gabel, Ramakant Sharma, 23 Fund, Climate Capital, Correlation Ventures, D4 Ventures, Esas Ventures, LUX Capital |
